Rapid determination of losartan in human plasma by LC-MS/MS and study on its bioequivalence

Ming HUANG,Quan-ying ZHANG,Shun-lin ZONG
DOI: https://doi.org/10.14053/j.cnki.ppcr.201704021
2017-01-01
Abstract:Objective To establish an LC-MS/MS method for the determination of losartan in human plasma,and evaluate the bioequivalence of losartan potassium tablet in healthy volunteers.Methods A single oral dose of test and reference formulations was given to 23 healthy male volunteers according to a randomized crossover design.Plasma concentration was determined by LC-MS/MS after deproteinized with methanol.The pharmacokinetic parameters were calculated by DAS 3.2.3.Results The main pharmacokinetic parameters of losartan in test and reference preparations were as follows:Cmax (697.3±301.7) and (674.1±350.5) ng/mL,AUC0-12 h (994±240) and (1 005±287) ng·h/mL,tmax (1.23±0.38) and (1.37±0.75) h,t1/2 (2.04±0.28) and (2.00±0.40) h,respectively.The relative bioavailability of test formulations was 102.4%±21.1%.Conclusion LC-MS/MS method is proved to be sensitive,convenient and accurate.Losartan potassium tablet is bioequivalent to the reference tablet.
What problem does this paper attempt to address?